These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 31234835)
21. Antifibrotic effects of cyclosporine A on TGF-β1-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1α. Yamazaki R; Kasuya Y; Fujita T; Umezawa H; Yanagihara M; Nakamura H; Yoshino I; Tatsumi K; Murayama T FASEB J; 2017 Aug; 31(8):3359-3371. PubMed ID: 28446589 [TBL] [Abstract][Full Text] [Related]
22. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis. Zhang L; Li Y; Liang C; Yang W Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150 [TBL] [Abstract][Full Text] [Related]
24. Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis. Huang Y; Guzy R; Ma SF; Bonham CA; Jou J; Schulte JJ; Kim JS; Barros AJ; Espindola MS; Husain AN; Hogaboam CM; Sperling AI; Noth I BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36725082 [TBL] [Abstract][Full Text] [Related]
25. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis. Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372 [TBL] [Abstract][Full Text] [Related]
26. Transcriptomic changes involved in the dedifferentiation of myofibroblasts derived from the lung of a patient with idiopathic pulmonary fibrosis. Suzuki K; Kim JD; Ugai K; Matsuda S; Mikami H; Yoshioka K; Ikari J; Hatano M; Fukamizu A; Tatsumi K; Kasuya Y Mol Med Rep; 2020 Aug; 22(2):1518-1526. PubMed ID: 32626975 [TBL] [Abstract][Full Text] [Related]
27. Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis. Leppäranta O; Pulkkinen V; Koli K; Vähätalo R; Salmenkivi K; Kinnula VL; Heikinheimo M; Myllärniemi M Am J Respir Cell Mol Biol; 2010 May; 42(5):626-32. PubMed ID: 19597127 [TBL] [Abstract][Full Text] [Related]
28. Hypoxia induces pulmonary fibroblast proliferation through NFAT signaling. Senavirathna LK; Huang C; Yang X; Munteanu MC; Sathiaseelan R; Xu D; Henke CA; Liu L Sci Rep; 2018 Feb; 8(1):2709. PubMed ID: 29426911 [TBL] [Abstract][Full Text] [Related]
29. TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis. Hou J; Ma T; Cao H; Chen Y; Wang C; Chen X; Xiang Z; Han X J Cell Physiol; 2018 Mar; 233(3):2409-2419. PubMed ID: 28731277 [TBL] [Abstract][Full Text] [Related]
30. Co-delivery of siPTPN13 and siNOX4 Hou J; Ji Q; Ji J; Ju S; Xu C; Yong X; Xu X; Muddassir M; Chen X; Xie J; Han X Theranostics; 2021; 11(7):3244-3261. PubMed ID: 33537085 [No Abstract] [Full Text] [Related]
31. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway. Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477 [TBL] [Abstract][Full Text] [Related]
32. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis. Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103 [TBL] [Abstract][Full Text] [Related]
33. Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis. Xie N; Tan Z; Banerjee S; Cui H; Ge J; Liu RM; Bernard K; Thannickal VJ; Liu G Am J Respir Crit Care Med; 2015 Dec; 192(12):1462-74. PubMed ID: 26284610 [TBL] [Abstract][Full Text] [Related]
34. Metformin attenuates lung fibrosis development via NOX4 suppression. Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730 [TBL] [Abstract][Full Text] [Related]
35. Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF). Barratt SL; Blythe T; Ourradi K; Jarrett C; Welsh GI; Bates DO; Millar AB Respir Res; 2018 Jan; 19(1):9. PubMed ID: 29334947 [TBL] [Abstract][Full Text] [Related]
38. Persistent hypoxia promotes myofibroblast differentiation via GPR-81 and differential regulation of LDH isoenzymes in normal and idiopathic pulmonary fibrosis fibroblasts. Nho RS; Rice C; Prasad J; Bone H; Farkas L; Rojas M; Horowitz JC Physiol Rep; 2023 Sep; 11(17):e15759. PubMed ID: 37653539 [TBL] [Abstract][Full Text] [Related]
39. Metabolic Profiling Regarding Pathogenesis of Idiopathic Pulmonary Fibrosis. Kang YP; Lee SB; Lee JM; Kim HM; Hong JY; Lee WJ; Choi CW; Shin HK; Kim DJ; Koh ES; Park CS; Kwon SW; Park SW J Proteome Res; 2016 May; 15(5):1717-24. PubMed ID: 27052453 [TBL] [Abstract][Full Text] [Related]